RHBC
DOX icon

R.H. Bluestein & Co’s Amdocs DOX Stock Holding History

R.H. Bluestein & Co’s Portfolio DOX Stock Details DOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,620
Closed -$218K – 350
2022
Q2 		$218K Sell
2,620
-250
-9% -$20.6K 0.01% 323
2022
Q1 		$236K Hold
2,870
– – 0.01% 347
2021
Q4 		$215K Hold
2,870
– – 0.01% 387
2021
Q3 		$217K Hold
2,870
– – 0.01% 388
2021
Q2 		$222K Sell
2,870
-1,175
-29% -$90.7K 0.01% 402
2021
Q1 		$284K Hold
4,045
– – 0.01% 324
2020
Q4 		$287K Buy
+4,045
New +$254K 0.01% 298

Other funds holding DOX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

R.H. Bluestein & Co's DOX Position: Q3 2022 in Review

R.H. Bluestein & Co sold out of Amdocs (DOX) in Q3 2022, closing a stake of 2,620 shares — an estimated $218K sold.

R.H. Bluestein & Co first reported a position in DOX in Q4 2020 and held it in 7 quarters. The position peaked at $287K in Q4 2020. 451 funds tracked by Wall St. Rank hold DOX as of Q3 2022.

  • R.H. Bluestein & Co reported no remaining Amdocs position as of Q3 2022 after selling out during the quarter.
  • R.H. Bluestein & Co sold 2,620 Amdocs shares in Q3 2022, an estimated $218K.
  • R.H. Bluestein & Co first reported a position in Amdocs in Q4 2020 and held it in 7 quarters.
  • R.H. Bluestein & Co's Amdocs position peaked at $287K in Q4 2020.
  • 451 funds tracked by Wall St. Rank held Amdocs as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.